An expert panel highlights key presentations in multiple myeloma, lymphoma, and other hematologic malignancies at the 2025 ASCO Annual Meeting.
Taha Al-Juhaishi, MD
Advertisement
Articles by Taha Al-Juhaishi, MD
Therapies such as betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
From Blunt Instruments to Molecular Precision: 40 Years of Oncology Evolution
2
FDA Type B Meeting Appears Successful for Givastomig in Gastric Cancers
3
Which Novel Drug Classes Hold Promise in Multiple Myeloma Therapy?
4
Treating Biochemical Recurrence in Oligometastatic Prostate Cancer
5